Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 571

What to do about the growing chorus of market correction warnings?

Since 2022, when the market slumped, I have repeatedly highlighted the possibility of stocks rising despite fears of a recession, which I assessed to be unfounded, and despite rising interest rates, which I believed would necessarily have to peak.

The reason for the optimism was simple; that economic growth would remain positive, albeit anaemic, and that disinflation would rule the day. As an aside, disinflation exists when prices are still rising but at consecutively lower rates of growth. The reason that combination of circumstances produced a bullish bias disposition in me was that since the 1970s, whenever positive economic growth and disinflation have joined forces, they have produced good conditions for equities, particularly the shares of innovative companies with pricing power.

Many of those innovative companies have indeed soared since 2022. I don’t need to list the returns of shares in Google, Meta, Apple, Microsoft and Nvidia over the last two years, or Spotify over the last twelve months. Innovative companies that can raise their prices without a detrimental impact on unit sales volume have indeed been the beneficiaries of a desirable combination of those two economic indicators.

Nvidia

Spotify

Source: Morningstar.com

I further believe it takes a few years for the prior bearish sentiment to turn 180 degrees and become a fully-fledged boom or even a bubble. This is because the unwinding of the bearishness that pervaded 2022 needs to overcome investor inertia, an uneven distribution of information and even the reassurance of rising prices needed by many investors. By the end of the switch in the narrative from bearish to bullish, microcap stocks, cryptocurrencies and even art, wine and collectible cars could all hit unprecedented highs.

Inevitably there are bumps along the way and few reputable investors are suggesting a big bump is coming.

The bear case

Indeed, warnings from reputable investors about an impending market correction are becoming increasingly prominent. Ruffer LLP, a UK-based investment firm, has already made its largest-ever bet on cash, reflecting its growing concerns about a violent market reversal driven by shrinking US liquidity. Similarly, Mark Spitznagel, known for his multi-billion dollar wins hedging against market downturns, echoes these concerns, predicting a severe market crash. And macroeconomic research house BCA Research has most recently forecast the S&P 500 to drop to 3750 points, equating to a 33% fall from the market’s mid-July high.

Ruffer LLP, managing approximately £22 billion, has allocated two-thirds of its assets to cash, a record high. The firm is funnelling the income from this cash into insurance policies, such as credit default swaps and US stock options, designed to profit from a significant decline in Wall Street.

Back in April, while discussing the subject with Bloomberg reporters, the firm predicted the predicted market reversal could happen within the next three months due to the Federal Reserve's ongoing reduction of liquidity. That would bring us to a correction this month. Recent volatility in prices, which has seen the S&P500 fall nearly 5%, and the NASDAQ nearly 8%, could render Ruffer LLC very prescient indeed, particularly if the slide continues.

Perhaps unusually for a fund manager, Ruffer takes a highly discretionary approach to managing its portfolios and concentrates its investments in a handful of asset classes, including a very successful bet on Bitcoin in 2020. The company’s approach also helped it achieve a 16% return during the 2008 financial crisis. But not every year is a success, with its funds missing out on the 2023 rally in equities, producing a 6% loss for the calendar year.

Ruffer argues that excessive optimism over potential future US interest rate cuts has left markets priced close to perfection, creating Black Monday-style liquidity risks. The firm believes that structural changes in inflation and interest rates indicate a higher trajectory for both, and as the US central bank winds down its QE-powered bond-buying program, liquidity dries up, and the risk of a market correction looms larger, with a 1987-style meltdown on the list of the firm’s possible scenarios.

Another bear is Mark Spitznagel, a protégé of Nassim Taleb and head of Universa Investments. He shares a similarly bleak outlook to Ruffer LLP. Universa provides long-only equity investors with hedges against fat tail risks – low-probability but high-impact market declines. Spitznagel's credibility is bolstered by Universa's performance, which has outpaced the S&P 500 over many years, and especially during the COVID-19 sell-off.

Spitznagel has consistently warned of an impending market crash worse than the Global Financial Crisis (GFC). He describes the current market as being in "the greatest credit bubble in human history" and predicts that stocks could lose up to 50% of their value. His strategy involves taking the opposite side of complex hedging tactics like Put-Spread Collars, which he deems unnecessarily complicated and expensive.

Despite his dire predictions, Spitznagel advises investors to remain passively invested in stocks, arguing that those who continue steady contributions to a fund despite alarming headlines will fare well in the long term. He believes the market is currently in a 'Goldilocks phase', with the rally likely to continue for several months, driven by a dovish Federal Reserve and bullish market sentiment. However, he cautions that rate cuts often signal an imminent market top, followed by a reversal.

Perhaps his advice – 'stay long, but something bad is coming' – is unsurprising; his firm does sell hedges against fat tail risks to long-only fund managers.

Best to ignore the doomsayers

I would not entertain warnings from the usual crowd of Henny Pennys that the sky is falling in because their secret to being successful with their predictions is simply to forecast often. The growing chorus of warnings from reputable investors like Ruffer LLP and Mark Spitznagel however suggests we should sit up and take notice.

I believe that as long as economic growth remains positive and inflation continues to slow, the conditions are positive for innovative growth companies. Perhaps the mega-cap tech stocks give ground to small caps, where many innovators reside and whose prices have not soared to anywhere near the same levels as the mega-cap tech stocks noted earlier.

As prices rise, however, the risks of setbacks also rise. This suggests, at a minimum, a heightened awareness of potential market risks is wise. While Ruffer prioritises capital preservation in anticipation of a market correction, Spitznagel advises staying long in the market and adding to portfolios when prices sell-off. As both firms adjust their strategies to navigate any uncertainty and volatility, we should at least pause and reflect on our own approaches.

 

Roger Montgomery is the Chairman of Montgomery Investment Management and an author at www.RogerMontgomery.com. This article is for general information only and does not consider the circumstances of any individual.

 

RELATED ARTICLES

Five reasons to hold your investment nerve

Not all private markets are ‘volatility laundering’

5 charts that should give investors hope amidst market turmoil

banner

Most viewed in recent weeks

Vale Graham Hand

It’s with heavy hearts that we announce Firstlinks’ co-founder and former Managing Editor, Graham Hand, has died aged 66. Graham was a legendary figure in the finance industry and here are three tributes to him.

Australian stocks will crush housing over the next decade, one year on

Last year, I wrote an article suggesting returns from ASX stocks would trample those from housing over the next decade. One year later, this is an update on how that forecast is going and what's changed since.

Taxpayers betrayed by Future Fund debacle

The Future Fund's original purpose was to meet the unfunded liabilities of Commonwealth defined benefit schemes. These liabilities have ballooned to an estimated $290 billion and taxpayers continue to be treated like fools.

Australia’s shameful super gap

ASFA provides a key guide for how much you will need to live on in retirement. Unfortunately it has many deficiencies, and the averages don't tell the full story of the growing gender superannuation gap.

Looking beyond banks for dividend income

The Big Four banks have had an extraordinary run and it’s left income investors with a conundrum: to stick with them even though they now offer relatively low dividend yields and limited growth prospects or to look elsewhere.

AFIC on its record discount, passive investing and pricey stocks

A triple headwind has seen Australia's biggest LIC swing to a 10% discount and scuppered its relative performance. Management was bullish in an interview with Firstlinks, but is the discount ever likely to close?

Latest Updates

Investment strategies

9 lessons from 2024

Key lessons include expensive stocks can always get more expensive, Bitcoin is our tulip mania, follow the smart money, the young are coming with pitchforks on housing, and the importance of staying invested.

Investment strategies

Time to announce the X-factor for 2024

What is the X-factor - the largely unexpected influence that wasn’t thought about when the year began but came from left field to have powerful effects on investment returns - for 2024? It's time to select the winner.

Shares

Australian shares struggle as 2020s reach halfway point

It’s halfway through the 2020s decade and time to get a scorecheck on the Australian stock market. The picture isn't pretty as Aussie shares are having a below-average decade so far, though history shows that all is not lost.

Shares

Is FOMO overruling investment basics?

Four years ago, we introduced our 'bubbles' chart to show how the market had become concentrated in one type of stock and one view of the future. This looks at what, if anything, has changed, and what it means for investors.

Shares

Is Medibank Private a bargain?

Regulatory tensions have weighed on Medibank's share price though it's unlikely that the government will step in and prop up private hospitals. This creates an opportunity to invest in Australia’s largest health insurer.

Shares

Negative correlations, positive allocations

A nascent theme today is that the inverse correlation between bonds and stocks has returned as inflation and economic growth moderate. This broadens the potential for risk-adjusted returns in multi-asset portfolios.

Retirement

The secret to a good retirement

An Australian anthropologist studying Japanese seniors has come to a counter-intuitive conclusion to what makes for a great retirement: she suggests the seeds may be found in how we approach our working years.

Sponsors

Alliances

© 2024 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.